ArticleDiscover oncology2025

COL22A1 expression identifies aggressive glioma and independently predicts survival through integrated multiomics and clinical validation.

Wei-Wen Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.